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onvisual arrestins (arr) modulate G protein–coupled
receptor (GPCR) desensitization and internalization
and bind to both clathrin (CL) and AP-2 components
of the endocytic coated pit (CP). This raises the possibility
that endocytosis of some GPCRs may be a consequence of
arr-induced de novo CP formation. To directly test this
hypothesis, we examined the behavior of green fluorescent
protein (GFP)-arr3 in live cells expressing 
 

 
2
 
-adrenergic
receptors and fluorescent CL. After agonist stimulation, the
diffuse GFP-arr3 signal rapidly became punctate and
colocalized virtually completely with preexisting CP spots,
demonstrating that activated complexes accumulate in
previously formed CPs rather than nucleating new CP
formation. After arr3 recruitment, CP appeared larger:
electron microscopy analysis revealed an increase in both
N
 
CP number and in the occurrence of clustered CPs. Mutant
arr3 proteins with impaired binding to CL or AP-2 displayed
reduced recruitment to CPs, but were still capable of inducing
 
CP clustering. In contrast, though constitutively present in CPs,
the COOH-terminal moiety of arr3, which contains CP
binding sites but lacks receptor binding, did not induce
CP clustering. Together, these results indicate that recruitment
 
of functional arr3–GPCR complexes to CP is necessary
 
to induce clustering. Latrunculin B or 16
 

 
C blocked CP
rearrangements without affecting arr3 recruitment to CP.
 
These results and earlier studies suggest that discrete
 
CP zones exist on cell surfaces, each capable of support-
 
ing adjacent CPs, and that the cortical actin membrane
skeleton is intimately involved with both the maintenance of
existing CPs and the generation of new structures.
 
Introduction
 
During clathrin (CL)* coated pit (CP)–mediated endocytosis,
coats form on the cytosolic side of the plasma membrane
through the assembly of CL triskelia by the tetrameric assem-
bly protein (AP-2). A potential link between the endocytic
pathway and extracellular stimuli is suggested by the ability
of several coat proteins to bind phosphoinositides produced
by receptor signaling (Norris et al., 1995; Ye et al., 1995;
Gaidarov et al., 1996; Gaidarov and Keen, 1999) and to
undergo reversible phosphorylation (Wilde and Brodsky,
1996; Slepnev et al., 1998; Chen et al., 1999; Chu et al.,
1999) in response to receptor stimulation.
Previous work from our laboratory showed that CPs
preferentially form at discrete locations on the cell membrane
and exhibit restricted lateral mobility (Gaidarov et al.,
1999b), suggesting that the membrane cytoskeleton may
function to anchor the coat assembly machinery. Furthermore,
the number and location of these CP formation sites was not
affected by increased levels of receptors on the plasma mem-
brane (Santini and Keen, 1996; Santini et al., 1998; Warren
et al., 1998). Nevertheless, in some cells, CP formation can
be rapidly induced in response to certain stimulants (e.g.,
EGF, NGF, carbachol) (Connolly et al., 1981, 1984;
Geisow et al., 1985; Wilde et al., 1999; Beattie et al., 2000),
further suggesting a functional relationship between signal-
ing receptors and the endocytic machinery, perhaps at the
level of actin-anchored CP formation sites.
Many GPCRs have been shown to undergo CL-mediated
endocytosis after stimulation, and arrestins (arr) (
 

 
arr and
arr3, also called 
 

 
arr1 and 
 

 
arr2, respectively) (Attramadal
et al., 1992), through their binding to both CL (Krupnick et
al., 1997a) and AP-2 (Laporte et al., 1999), are pivotal in
directing and concentrating activated GPCR into CPs for
internalization (Goodman et al., 1996; Zhang et al., 1997).
Arr are also thought to play a broader role as scaffolding pro-
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teins in the formation of signaling platforms under stimu-
lated GPCR (for a reviews see Ferguson, 2001; Miller and
Lefkowitz, 2001; Pierce et al., 2001).
Here we have investigated responses of the endocytic ma-
chinery to GPCR activation. We show that the activated
GPCR–arr3 complexes do not recruit coat components to
form new CPs, but rather undergo endocytosis as a conse-
quence of their rapid accumulation in preexisting CPs.
However, cells responded to agonist stimulation by increas-
ing the number and clustering of their CPs. Remarkably, re-
arrangement of the cortical actin membrane skeleton ap-
pears to be required to support formation of these clustered
CPs. Our results thus provide evidence for the existence of
actin-dependent geographically distinct assembly domains
on the cell surface which we term “coated pit zones” (CPZ).
 
Results
 
Arr3 is recruited to preexisting CPs
upon agonist activation
 
To directly determine whether activated GPCRs induce for-
mation of new CPs or accumulate in preexisting structures,
we visualized the behavior of both CPs and arr in living cells
following agonist stimulation. HEK293 cells expressing
DsRed-CL were cotransfected with green fluorescent pro-
tein (GFP)-arr3 and Flag-tagged 
 

 
2
 
-adrenergic receptor
(AR). In the absence of agonist, GFP-arr3 was predomi-
nantly diffuse (Fig. 1 A, and frame 1 of Video 1). In con-
trast, the DsRed-CL signal, as reported previously (Gaidarov
et al., 1999b; Engqvist-Goldstein et al., 2001), was present
in punctate endocytic CPs at the plasma membrane (Fig. 1)
and in the perinuclear localization characteristic of the TGN
(Keen et al., 1981). 
Within seconds after isoproterenol (ISO) addition there
was a striking concentration of arr3 signal in punctate spots
which colocalized with DsRed-CL signal (Video 1, frames
11–15). With time, a gradual decrease in the level of diffuse
arr3 signal also became apparent (compare first with last
frame of Video 1), consistent with recruitment of arr from a
cytosolic pool to the receptor at the plasma membrane.
Comparison of the emerging GFP-arr3 spots with the punc-
tate DsRed-CL signal marking CPs revealed that virtually all
of the arr3 puncta appeared at loci of preexisting CPs (Fig.
1, and frames 11–30 of Video 1). For example, of 130 arr3
spots detectable 40 s after ISO addition (frame #20), 128
(98.5%) appeared at preexisting CP sites (i.e., CPs present
in frame # 7). In subsequent frames both signals can be seen
to disappear together, consistent with internalization of the
arr–
 

 
2
 
-AR complex by CP-mediated endocytosis (Video 1).
Similar results were observed in transfected COS1 cells (un-
published data). These results provide direct evidence that
the endocytic sequence initiated by activation of 
 

 
2
 
-AR re-
sults in recruitment of arr3-receptor complexes to preexist-
ing CPs. Video 1 is available at http://www.jcb.org/cgi/content/
full/jcb.200110132/DC1.
 
CP changes are induced by 
 

 
2
 
-AR activation
 
In agonist-stimulated live cells we also observed significant
changes in the appearance and distribution of plasma
membrane CPs (unpublished data), but monitoring live
cells over extended periods presents technical difficulties.
Accordingly, we used immunostaining to more easily in-
vestigate these changes in COS1 cells transiently expressing
 

 
2
 
-AR and arr3. As expected from the results described
above and earlier work (Goodman et al., 1996; Krupnick
et al., 1997b), after ISO stimulation for 5 min arr3 became
colocalized with CL (Fig. 2 A). Under these conditions we
noted that CPs adopted an altered distribution, with the
CL puncta on the plasma membrane appearing both no-
ticeably larger and, to some extent, fewer in number com-
pared with those of nonexpressing cells in the same field.
Because AP-2 is a structural component of plasma mem-
brane CPs but, unlike CL, is not present in the TGN
(Robinson, 1987), we used AP-2 labeling as a more direct
indicator of endocytic CP changes upon agonist treatment.
Following ISO stimulation of arr3-expressing cells, AP-2–
labeled CPs underwent redistribution similar to that ob-
served with CL (Fig. 2 B). Interestingly, we noticed that
the AP-2 spots had become not only larger but also
brighter after agonist stimulation, amounting to a 4–8-fold
increase in comparison to neighboring nonexpressing cells.
We also found that arr2 (
 

 
arr1), although capable of trans-
locating to CPs and of mediating the internalization of ac-
tivated 
 

 
2
 
-AR upon expression in COS1 cells (Goodman
Figure 1. Agonist activation induces recruitment of arr3 to 
preexisting CPs. HEK293 cells coexpressing GFP-arr3, DsRed-CL, 
and Flag-tagged 2-AR were viewed as described in Materials and 
methods. A is frame 1 of Video 1 and shows the distribution of 
DsRed-CL and GFP-arr3 27 s before addition of ISO (10 M) to the 
cells. B is frame 20 of Video 1, acquired 73 s after stimulation and 
shows the redistribution of GFP-arr3 to preexisting CPs (arrows). 
Video 1 is available at http://www.jcb.org/cgi/content/full/
jcb.200110132/DC1.
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et al., 1996), was much less effective in inducing changes
in CP distribution (unpublished data).
To investigate whether 
 

 
2
 
-AR is able to induce alter-
ations in CP properties in the absence of exogenous arr3
expression, we used RBL(
 

 
2
 
) cells, an RBL-2H3 subline
that stably expresses Flag-tagged 
 

 
2
 
-ARs (Santini et al.,
2000). RBL cells express detectable levels of endogenous
arr, making them an ideal system to study cellular re-
sponses to GPCR stimulation. Additionally, we have
shown recently that treatment of these cells with ISO in-
duces the selective recruitment of endogenous arr3 to
CPs (Santini et al., 2000). Following ISO stimulation of
RBL(
 

 
2
 
), examination of CP localization by immuno-
staining with either CL (unpublished data) or AP-2 anti-
bodies (Fig. 3) revealed arr3 accumulation in larger CPs
with increased AP-2 signal, similar to that observed in
COS1 cells.
 
m1 muscarinic receptor activation induces 
clustering of CPs
 
To probe whether the ability to alter CP patterns was
shared by other GPCRs, we examined RBL-2H3 cells
(RBL[m1]) stably expressing m1 acetylcholinergic recep-
tors (m1AChR). Signaling events following agonist activa-
tion of the m1AChR in RBL-2H3 cells have been studied
extensively (Jones et al., 1991; Hirasawa et al., 1995; Dip-
pel et al., 1996) and include arr3 recruitment to CPs and
m1AChR internalization (Santini et al., 2000). As ob-
served after stimulation of 
 

 
2
 
-AR in COS1 cells, stimula-
Figure 2. Changes in CP appearance upon 2-AR activation. 
Following treatment with ISO, COS1 cells coexpressing Flag–2-AR 
and arr3 show recruitment of arr3 to CPs, increase in CP size, and 
increased CP AP-2 signal in comparison to arr3-nonexpressing cells. 
(A) COS1 cells transiently expressing Flag–2-AR and arr3 were 
stimulated with ISO (10 M, 5 min), fixed, and stained for CL and 
arr3. (B) COS1 cells transiently expressing Flag–2-AR and arr3 
were stained for AP-2 and arr3 after stimulation with ISO (10 M, 
5 min). Bar, 10 m.
Figure 3. Changes in plasma membrane CPs in RBL cells following 2-AR stimulation. RBL(2) cells stably expressing Flag–2-AR show 
formation of larger CPs with increased AP-2 signal as well as recruitment of endogenous arr3 (arr3) to CPs after stimulation with ISO (ISO) 
(10 M, 5 min). Insets show fourfold magnified views of the boxed region of the cells. Bar, 10 m.
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tion of RBL(m1) cells with the agonist carbachol (CBC)
resulted again in CL puncta on the plasma membrane be-
coming noticeably larger than those observed in unstimu-
lated cells (Fig. 4, compare A to B).
 
Digital image analysis of immunofluorescence CP spots
 
The apparent size of spots in fluorescence microscopy, espe-
cially for objects such as CPs that are at or below the diffrac-
tion limit, is a function of both the object size and relative
brightness. Thus, a trivial explanation for the larger apparent
size of CPs revealed by CL staining in stimulated cells could
be that the individual spots are simply brighter. However,
measurement of mean CL pixel intensities of spots in images
from agonist-treated and untreated RBL(m1) cells collected
under identical instrument settings revealed no significant
change in spot brightness (Table I). Rather, almost a dou-
bling in the apparent CP spot size and a drop in the appar-
ent density of CPs was observed (Table I). These results sug-
gest that the physical size and/or distribution of CPs on the
cell was indeed altered by agonist activation of m1AChRs.
When RBL(m1) cells were stained for AP-2
 

 
 the puncta
in agonist-stimulated cells appeared larger (Fig. 4, compare
C to D), consistent with the changes in the appearance of
CL (Fig. 4, A and B). Furthermore, the AP-2 signal in these
spots was also brighter compared with CP spots in unstimu-
lated cells, though less pronounced than the increase ob-
served in COS1 cells in response to 
 

 
2
 
-AR stimulation. To
assess whether these larger and brighter spots indeed re-
Figure 4. m1AChR stimulation induces changes in plasma membrane CPs. Stimulation of resting RBL(m1) cells (A) with CBC (1 mM, 3 min) 
induces the formation of larger CPs (B) as revealed by immunostaining for CL. Confocal microscopy images of untreated (C) or CBC-treated 
cells (D) immunostained for AP-2 also reveals the appearance of larger CPs with greatly increased AP-2 signal. These CPs are appropriately 
restricted to the plasma membrane (x-z sections; E and F). The confocal images were acquired and reproduced using identical gain settings 
and the same minimum and maximum display values for each unstimulated/stimulated pair. (G) Lower magnification views of changes in 
AP-2–labeled CPs over a 3 min period following stimulation. Bars: 10 m.
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flected CPs at the cell surface rather than aberrant internal
structures, we used confocal 
 
x-z
 
 sectioning of AP-2–immu-
nostained cells. The images (Fig. 4, E and F) confirmed that
the CPs were indeed restricted to the cell periphery as ex-
pected. In RBL(m1) cells marked changes in CP properties
occurred between 1–3 min (Fig. 4 G). In the continued
presence of agonist the altered CP profiles persisted, subsid-
ing gradually after 10–15 min.
All of the properties noted above following GPCR stimu-
lation were consistently observed when multiple antibodies
against CL (mAb X22 or polyclonal R5, COM, 27004) or
AP-2 (mAb AP.6 or polyclonal #31) were employed. In ad-
dition, varied fixation conditions, compatible with specific
antibodies, all gave similar results.
 
Ultrastructural analysis of agonist-induced changes 
in CP profiles
 
To learn more about agonist-induced changes in CP appear-
ance, we examined control and treated RBL(m1) cells by
electron microscopy. As can be seen from the examples pre-
sented in Fig. 5, both untreated (A) and CBC-treated cells
(B–I) show similar characteristic, bristle-coated indentations
of the cell surface typical of CPs. These images confirmed
that the altered appearance of CPs at the light microscopy
level after agonist treatment did not reflect gross malforma-
tion of coat structures, e.g., accumulation of empty lattices
or CL aggregates that have been seen under nonphysiologi-
cal conditions (Merisko et al., 1986; Sandvig et al., 1988;
Heuser and Anderson, 1989).
However, quantitative analysis of these images did reveal
several significant changes in CP distribution (Table II).
First, stimulation of RBL(m1) cells with CBC for 3 min
produced a 50% increase in the number of CPs (
 
P
 
 
 

 
0.001). Second, a twofold increase in the proportion of shal-
low and flat CPs at the expense of deep CPs was observed af-
ter stimulation. Most striking in the treated samples was a
noticeable increase in the frequency with which CPs ap-
peared to occur in close proximity to other CPs, i.e., the CPs
appeared to be clustered, with the rim of one pit almost
touching that of another (Fig. 5, C and E), suggesting the
existence of CPZs. In the extreme example shown in Fig. 5
H, an extended region of coated membrane is visible, com-
prised of six or seven contiguous but discrete coated struc-
tures. In other instances, adjacent indented CPs appear to
share the same opening (Fig. 5, I and G). To quantitatively
analyze this phenomenon, we characterized CPs that were
within 0.3 
 

 
m of each other as being ‘clustered’, i.e., essen-
tially not resolvable by light microscopy. By this conserva-
tive criterion, the occurrence of clustered CPs increased 2.5-
fold (
 
P
 
 
 

 
 0.001) in cells that had been stimulated for 3 min
(Table II). However, the number of CPs in a given cluster
was not changed by CBC treatment, and was between two
and three on average (control 
 

 
 2.27 
 

 
 0.55 SD [
 
n
 
 
 

 
 31
clusters] and CBC 
 

 
 2.29 
 

 
 0.56 SD [
 
n
 
 
 

 
 57]). Thus, the
dramatic appearance of larger CPs observed at the light mi-
croscope level (Figs. 2 and 4 and Table I) following agonist
activation likely reflects multiple factors: the increase in
number and clustering of CPs detected ultrastructurally, the
intensified signal associated with these structures, and the
limited resolution of the fluorescence light microscope.
 
Mobilization of arr3 to CPs and onset of CP clustering 
are separable events
 
The ultrastructural results we obtained prompted us to con-
sider in more detail the relationship between translocation of
arr to CPs and the onset of clustering. In unstimulated
RBL(m1) cells some punctate arr3 signal could be detected,
but virtually none was coincident with CPs; in fact, the two
 
Table II. 
 
Ultrastructural changes in CP properties upon agonist stimulation
Coated structures
 
a
 
Shallow pits
 
b
 
Deep pits
 
c
 
Clusters
 
a,d
 
Coated structures in clusters
 
d
 
per 
 

 
m % % per 
 

 
m %
 
Control 0.2 
 

 
 0.02 (
 
n
 
  
 
36)
 
e
 
18.4 81.6 0.02 
 

 
 0.003 (
 
n
 
  
 
36)
 
f
 
19.3
CBC 0.3 
 

 
 0.03 (
 
n
 
  
 
26)
 
e
 
38.7 61.3 0.05 
 

 
 0.009 (
 
n
 
  
 
26)
 
f
 
35.5
A total of 1.81 mm (Control) and 1.26 mm (CBC) of plasma membrane were analyzed. Coated structures were classified as described in Materials and
methods.
 
a
 
Data are means 
 

 
 SEM.
 
b
 
”Shallow pits” include flat coated regions of plasma membrane; 3.3% and 7.3% of the total in control and CBC-treated cells, respectively.
 
c
 
”Deep pits” include deeply invaginated–coated membranes and putative-coated vesicles (see Materials and methods). These “coated vesicles” accounted
for 33 and 23.1% of the total in control and CBC-treated cells, respectively.
 
d
 
Clusters are defined as coated structures within 0.3 
 

 
m of each other. Clusters contained 2.27 
 

 
 0.55 SD (
 
n
 
 = 31 clusters) and 2.29 
 

 
 0.56 SD (
 
n
 
 = 57)
coated structures in control and CBC-treated cells, respectively.
 
e
 
The differences are statistically significant (
 
P
 
 
 
 
 
0.001).
 
f
 
The differences are statistically significant (
 
P
 
 
 

 
 0.001).
Table I. 
 
Changes in CP properties upon agonist stimulation characterized by light microscopy
Basal Stimulated
 
Mean brightness
 
a
 
334.37 
 

 
 5.22 (
 
n
 
 
 

 
 15) 376.85 
 

 
 8.1 (
 
n
 
 
 

 
 24)
Spot density
 
b
 
18.9 
 

 
 1.18 (
 
n
 
 
 

 
 15) 12.8 
 

 
 0.9 (
 
n
 
 
 

 
 24)
Average spot size
 
c
 
9.07 
 

 
 0.76 (
 
n
 
 
 

 
 284) 18.46 
 

 
 1.89 (
 
n
 
 
 

 
 306)
 
a
 
Average integrated pixel intensity 
 

 
 SE in a 5.4 
 
	
 
 5.4 
 

 
m box. See Materials and methods for details.
 
b
 
Average number of spots 
 

 
 SE in a 5.4 
 
	
 
 5.4 
 

 
m box. See Materials and methods for details.
 
c
 
Average size of a spot 
 

 
 SE in square pixels. See Materials and methods for details. 
 
n
 
, number of spots.
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mations followed rapidly. It was also possible to appreciate
that arr3 recruitment preceded the agonist-induced increase
in AP-2 brightness in these cells (Fig. 7, compare 15” to
30”), though the latter could not be resolved from changes
in CP patterns (unpublished data).
We were further able to distinguish between arr recruit-
ment to CPs and CP changes by stimulating COS1 cells at
reduced temperature. Cells transiently expressing Flag–
 

 
2
 
-
AR and arr3 were stimulated with ISO at 16
 

 
, and arr3 and
AP-2 immunostaining were compared with that of cells
stimulated at 37
 

 
C. As expected (Cao et al., 1998), agonist
was able to mobilize arr3 to CPs readily in both sets of cells.
However, cells kept at 16
 

 
C for up to 45 min failed to show
changes in the pattern of CPs (unpublished data). Similar
results were obtained upon CBC stimulation of RBL(m1)
cells at reduced temperature (unpublished data).
Next we evaluated the effect of either agonist removal or
antagonist administration upon CP changes. Addition to
CBC-stimulated RBL(m1) cells of the m1AChR antagonists
Figure 5. Ultrastructural analysis reveals increased plasma membrane CP clustering in CBC-stimulated RBL(m1) cells. Compared with 
unstimulated cells (A), agonist stimulation (1 mM, 3 min) produced an increase in the occurrence of nearby or adjacent CPs (B–I). These 
clusters, which often comprised multiple distinct membrane-coated regions, included pits at different stages of invagination (B–F, and H). See 
text for details. Bar, 0.2 m.
 
signals are remarkably separate (Fig. 6, A–C). Within 30 s
after addition of agonist, some localization of arr3 to CPs is
detectable, though no significant clustering of pits is appar-
ent (Fig. 6, D–F). After 1 min of stimulation (Fig. 6, G–I),
large CPs could be detected with some frequency. Interest-
ingly, at early times arr3 was often seen to localize to only
one of two adjacent AP-2 spots (Fig. 6, G, H, J, and K, ar-
rows): at 30 s, 66% of clusters have arr3 in only one of the
two adjacent CPs (
 
n
 
 
 

 
 46). This is suggestive of the pres-
ence of arr3 in only one of a nascent cluster of two or more
adjacent CPs (Fig. 6, see merged panels and arrows). This
phenomenon was less pronounced at longer times after ago-
nist stimulation.
Generally similar results were seen in COS1 cells coex-
pressing 
 

 
2
 
-AR and arr3, though the changes occurred more
rapidly. Here, stimulation with ISO induced readily detect-
able arr recruitment to CPs in most cells as early as 15 s (Fig.
7). At this point, only a small fraction of cells displayed de-
tectable changes in CP distribution, though these transfor-
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atropine or pirenzepine (Fig. 6, P–R, and unpublished data),
which immediately block agonist-induced tyrosine phosphor-
ylation (unpublished data) and histamine release (Jones et al.,
1991), caused essentially immediate disappearance of arr3.
However, in both cases, the clustered CP persisted for at least
several minutes (Fig. 6 P). Similar results were observed in
ISO-stimulated COS1 cells expressing arr3 and 
 

 
2
 
-AR upon
agonist washout or upon addition of the antagonist alprenolol
(unpublished data). Collectively, these results indicate that
arr3 recruitment to CPs precedes, and is distinct from, reorga-
nization of CP patterns on the surface of the cell. However,
once established, maintenance of the clustered CP phenotype
does not require the continued presence of arr3.
 
Arr3 determinants sufficient for CP localization do not 
support CP reorganization
 
Alteration of specific residues in arr3 have been described that
result in substantial loss of CL (Krupnick et al., 1997a) or AP-2
(Laporte et al., 2000) binding. To investigate the contribution
of these sites to the ability of arr3 to induce changes in CP dis-
tribution, we cotransfected COS1 cells with Flag–
 

 
2
 
-AR and
with a mutant construct coding for arr3 with either impaired
CL (LIF/A) or AP-2 (R396A) binding. Upon agonist treat-
ment, recruitment of either mutant arr to CPs was substantially
reduced in comparison to the wild-type protein (Fig. 8, WT),
as was expected from previous work (Krupnick et al., 1997a;
Laporte et al., 2000). However, close inspection did reveal clear
examples of colocalization of each of the mutant arr with AP-2
in CPs. Importantly, when detected in CPs, both mutants were
able to induce clustered CP formation and to increase CP-asso-
ciated AP-2 (Fig. 8, compare arr-expressing with nonexpressing
cells). These results indicate that neither mutation fully abro-
gates the arr3–CP interaction in the context of the intact cell.
Nevertheless, despite impaired CL or AP-2 binding, if success-
fully recruited to CPs these proteins apparently retain the abil-
ity to initiate changes in CP patterns on the cell surface.
Previous work has shown that constructs coding for the
COOH-terminal half of arr lack high affinity interaction
with receptors but retain CL and AP-2 binding determi-
nants and are constitutively localized in CPs in the absence
of agonist (Krupnick et al., 1997b). We used such a con-
struct (C-ter, see Materials and methods) to attempt to dis-
tinguish between arr-coat binding and CP clustering. Upon
transient expression in COS1 cells, C-ter was prominently
localized to CPs in the absence (unpublished data) as well as
the presence of agonist (Fig. 8). However, no changes in CP
distribution or AP-2 brightness were evident in comparison
to control cells. Together, these results indicate that stable
occupancy of arr binding sites on the CP lattice is necessary
but not sufficient for initiating events leading to reorganiza-
tion of CPs on the cell surface. Rather, the formation of a
complex between arr3 and agonist-activated receptors is
likely to be a prerequisite to the changes observed.
 
Latrunculin B blocks CP reorganization in stimulated cells
 
The observation that the presence of the CP binding region of
arr3 in CPs is insufficient to induce CP reorganization indi-
cated that other components were also required. To probe
whether signaling initiated by GPCR activation was involved,
Figure 6. Endogenous arr3 is often concentrated in one CP within 
a cluster and CP clusters, but not arr3, persist after antagonist 
treatment. RBL(m1) cells were stimulated with CBC (1 mM) for 0 
(A–C), 0.5 (D–F), 1 (G–I), 3 (J–L), or 6 min (M–O). At zero time 
(A–C), endogenous arr3 (red) was not coincident with CPs, marked 
by AP-2 (green). Some coincidence of the two signals is evident 
within 30 s of CBC addition (D–F, arrows). Between 1–3 min after 
agonist treatment, arr3 is often localized within one of two adjacent 
CPs (G–L, arrows), less resolvable at later times (M–O). Note that 
the degree of CP clustering does not correlate closely with intensity 
of arr3 signal (M–O, arrowheads). P–R show cells treated for 3 min 
with CBC (1 mM) followed by the antagonist atropine (10 M) for 3 
min. Under these conditions, arr3 has been virtually completely 
removed from the CPs but the clustered CP phenotype remains 
unchanged. Bar, 3 m.
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RBL(m1) cells were pretreated with AlF
 


 
4
 
 (30 
 

 
M, 3 min),
cholera (1 
 

 
g/ml, 4 h), or pertussis (0.1 
 

 
g/ml, 4 h) toxins to
target the heterotrimeric G proteins G
 

 
s
 
 and G
 

 
i
 
. These treat-
ments did not detectably impair the agonist-induced CP re-
sponse (unpublished data), indicating that signaling through
these G proteins is not involved in the reorganization of CPs
upon agonist stimulation. In addition, RBL(m1) cells were
pretreated with EGF receptor kinase targeted (AG1478; 10
 

 
M, 10 min) or broad-spectrum protein kinase inhibitors
(quercetin; 10 
 

 
M, 10 min), as well as the src family kinase in-
hibitor PP1 (10 
 

 
M, 15 min) (Hirasawa et al., 1995; Wilde et
al., 1999). None of these treatments blocked agonist-activated
changes in CP distribution on the cell surface, or induced their
occurrence in unstimulated cells (unpublished data).
Finally, we also tested a number of agents that affect cell ul-
trastructure. Pretreatment with either colchicine (10 
 

 
g/ml,
30 min) or cytochalasin D (2 
 

 
M, 20 min) did not induce
changes in CP distribution nor inhibit the effects of 
 

 
2
 
-AR or
m1AChR stimulation (unpublished data). However, brief in-
cubation with the G-actin sequestering agent latrunculin B
(0.6 
 

 
g/ml, 3 min) was sufficient to completely block both
the CBC-induced changes in CP clustering and increased AP-2
recruitment in RBL(m1) cells (Fig. 9, and compare with Figs.
3 and 6). Under these conditions, significant drug-induced
actin rearrangement was also observed (unpublished data). In-
terestingly, recruitment of arr3 to CPs was not detectably af-
fected by latrunculin B treatment (Fig. 9, 
 

 
).
 
Discussion
 
Nonvisual arrestins play critical roles in the internaliza-
tion of GPCRs in vivo. Because they bind both CL and
AP-2 in vitro, it has been suggested that arr could mediate
the assembly of CL coats beneath the activated GPCR–arr
complex by directly recruiting coat proteins (Zuker and
Ranganathan, 1999; Laporte et al., 2000). Several studies
from our laboratory and others have found no direct rela-
tionship between CP formation and the overall density
of receptors undergoing either constitutive or stimulus-
induced internalization (Santini and Keen, 1996; Santini
et al., 1998; Warren et al., 1998). However, in some cells
CP formation can be rapidly induced in response to acti-
vation of some signaling receptors (Connolly et al., 1981,
1984; Geisow et al., 1985; Wilde et al., 1999; Beattie et
al., 2000), indicating that physiological mechanisms exist
that regulate CP levels. In view of these findings, the po-
tential role of GPCRs and arr in CP formation and dy-
namics deserved investigation.
Figure 8. Clustering of CPs requires recruitment of functional 
arr3. COS1 cells expressing Flag–2-AR and either wild-type arr3 
(WT), arr3 with impaired AP-2- (R396A) or CL-binding (LIF/A), or 
arr3 284–409 (C-ter) were stimulated with ISO (10 M, 5 min).
Although the extent to which either of the mutant full-length arr3 
proteins was recruited to CPs (AP-2, left) was greatly diminished, 
each was capable of inducing formation of the larger, clustered CPs. 
However, the COOH-terminal domain of arr3, which colocalized 
with AP-2 in the absence (unpublished data) or presence (C-ter) of 
agonist, was incapable of inducing this change in CP appearance. 
Insets show fourfold magnification of the boxed area of the cell. 
Bar, 10 m.
Figure 7. Changes in CP morphology and distribution follow 
arr3 recruitment to CPs. Recruitment of arr3 to CPs (AP-2) can be 
visualized after only 15 s (15”) of ISO (10 M) stimulation in COS1 
cells transiently expressing 2-AR and arr3. At this time, the 
appearance of CPs in the arr3-expressing cells is indistinguishable 
from that in nonexpressing counterparts. Subsequent to arr3 recruit-
ment (30”), increases in CP size and in AP-2 signal become apparent. 
Note that there is little proportionality between the levels of arr3 and 
the AP-2 spot size and brightness (see arrowheads in insets). Insets are 
fourfold magnified view of the cell area boxed. Bar, 10 m.
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Our live cell studies with GFP-arr3 provide direct evi-
dence that activated receptor–arr complexes are targeted to
and accumulate in preexisting CPs, which then undergo
physiological internalization. These results argue for a
highly restricted distribution of CP assembly sites (see be-
low), consistent with previous observations (Estes et al.,
1996; Santini and Keen, 1996; Gonzalez-Gaitan et al.,
1997; Santini et al., 1998; Gaidarov et al., 1999b).
Though the GPCR–arr3 complex does not nucleate CPs,
after stimulation of 
 
2-AR or m1AChR and recruitment of
the GPCR–arr3 complex to CPs we observed a change in
the number and distribution of plasma membrane CPs.
This response was rapid, agonist- and temperature-depen-
dent and required GPCR and arr3 recruitment to CPs.
These changes must be distinct from those involved in the
membrane ruffling that occurs in response to activation of
many receptors (Beck et al., 2001): stimulation of RBL
cells via the FcRI receptor (Apgar, 1990) or by PMA (Ap-
gar, 1995) causes membrane ruffling and changes in actin
microfilaments (see below), but fails to induce the CP rear-
rangements elicited by 2-AR or m1AChR activation re-
ported here (unpublished data).
Agonist stimulation of GPCRs often initiates transactiva-
tion of other receptors, including receptor tyrosine kinases
(Luttrell et al., 1999). Though tyrosine phosphorylation of
CL heavy chain has been suggested to affect CPs (Wilde et
al., 1999), no CL heavy chain phosphorylation was detect-
able upon agonist stimulation (unpublished data). More-
over, inhibitors of the EGFR kinase (AG1478), of Src and
Src-related kinases (PP1), and a broad spectrum tyrosine ki-
nase inhibitor (quercetin) all failed to block CBC-stimulated
CP changes (unpublished data), though the latter two re-
agents (Hirasawa et al., 1995; Amoui et al., 1997) did block
degranulation and blunt overall phosphotyrosine production
following FcRI or m1AChR activation in our hands (un-
published data). Thus, tyrosine kinases do not appear to play
a role in these CP changes.
The CP response was elicited by stimulation of 2-AR and
m1AChR, which work through distinct G-proteins (Gs
and Gq/11, respectively) and effectors (adenylate cyclase and
PLC, respectively). In addition, incubation with cholera or
pertussis toxins or AlF
4 did not affect the CP response me-
diated by either receptor. Further, treating the cells with for-
skolin in the presence of cAMP phosphodiesterase inhibitors
also was without effect (unpublished data). However, physi-
cal recruitment of competent, even if binding impaired,
arr3–GPCR complexes to CPs was required for CP increases
and clustering (Fig. 8). Together, these results suggest that
the CP changes require: (a) formation of a complex between
arr3 and activated receptors; (b) the presence of additional
factor/s recruited to the arr–receptor signaling complex;
and/or (c) downstream signaling by the activated GPCR–arr
complex distinct from that mediated by Gs/Gi trimeric G
proteins.
GPCR stimulation resulted in increased AP-2 signal asso-
ciated with CPs, without a concomitant increase in the CL
signal. Interestingly, despite the variation in AP-2/CL pro-
portions the lattice size of CPs upon GPCR stimulation re-
mained unaffected as confirmed by direct ultrastructural
analysis (unpublished data). Increases in AP-2 brightness
have been noted previously following GPCR stimulation
(Laporte et al., 1999), and variation in AP-2/CL ratios are
also known to occur (Brown et al., 1999; Keren et al.,
2001). Stoichiometric AP-2/arr3 binding (Laporte et al.,
1999) is unlikely to explain this phenomenon, as their sig-
nals were not generally proportional (Fig. 7, arrowheads).
Alternatively, additional AP-2 may have bound directly to
unoccupied sites on the CL lattices (Keen et al., 1991) indi-
rectly through interaction with other coat-associated pro-
teins, or to nearby potential assembly sites in response to
GPCR activation.
Ultrastructural analysis of stimulated cells revealed both
an increase in the number of CPs and in the proportion of
CPs occurring in clusters. Together, these changes likely ac-
count for the striking apparent increase in CP size observed
by light microscopy. Arr3 recruitment to preexisting CPs is
the earliest detectable response to GPCR activation. How-
ever, there is an intervening period, before frankly larger CPs
are observed, in which arr3 is detected in only one of a pair
of adjacent CPs (Fig. 6). Based on these images and the ul-
trastructural data, we propose that initial accumulation of
arr3–GPCR complexes in preexisting CPs induces the for-
mation of nearby CPs that do not contain, at least initially,
any arr3. These new CPs then rapidly become loaded with
arr3–GPCR complexes.
One reagent effective in blocking agonist-induced CP clus-
tering was latrunculin B, which acts by sequestering G-actin
monomers (Spector et al., 1983, 1989; Coue et al., 1987).
Figure 9. Latrunculin B inhibits agonist-induced CP clustering. 
RBL(m1) cells were treated with latrunculin B for 3 min before 
treatment for 5 min with vehicle (
) or CBC (). Cells were fixed, 
permeabilized, and immunostained for AP-2 and arr3. Latrunculin B 
did not affect CP appearance (AP-2) in unstimulated cells (
) nor 
did it inhibit agonist-induced arr3 recruitment to CPs (, insets, 
arrows). However, it did block CP clustering and the rise in CP-
associated AP-2. Insets are fourfold magnified views of the cell area 
boxed. Bar, 10 m.
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There is ample evidence to suggest that actin plays a role in
endocytosis (Lamaze et al., 1997; Munn, 2001) and several
coat and associated proteins bind to or regulate actin assem-
bly (Engqvist-Goldstein et al., 2001; Hussain et al., 2001).
Furthermore, several members of the Rho family of small
GTPases are known to be involved in both CL endocytosis
and in actin rearrangements induced by receptor signaling
(Lamaze et al., 1996; Yang et al., 2001).
Interestingly, cytochalasin D, a drug that inhibits actin po-
lymerization by capping the barbed end of existing actin fila-
ments and thereby preventing their elongation (Spector et al.,
1989), was ineffective in blocking the GPCR-induced CP
changes. These results extend our previous observations in
which we found that treating cells with latrunculin but not
cytochalasin increased the lateral movement of CPs in the
plasma membrane (Gaidarov et al., 1999b). Together, they
argue that the CP machinery is intimately connected to a cor-
tical actin network, often resistant to cytochalasin (Cooper,
1987) but susceptible to latrunculin (Cassimeris et al., 1990),
and which provides a fence-like restriction to the movement
of established CPs (Gaidarov et al., 1999b). Further, actin re-
arrangements upon agonist stimulation appear to provide
conditions necessary for the assembly of new clustered CPs.
Work from our lab and others has established that en-
docytic CPs occur at defined loci, rather than being ran-
domly distributed on the cell surface. The results presented
here suggest that these sites should actually be envisaged as
CPZs, capable of supporting formation of adjacent, clus-
tered CPs. Conversely, substantial expanses of cell surface
lack this capability at any given time. We propose that each
CPZ exists as a discrete, comparatively stable plasma mem-
brane–cytoskeleton domain with micron dimensions, per-
haps analogous to raft structures whose properties are being
increasingly appreciated (Ikonen, 2001). Within each CPZ,
an actin framework may help to physically organize the as-
sembly of signaling complexes and provide a mechanical ba-
sis for inter-CPZ movements. The clustered distribution of
CPs, in turn, could facilitate functional cross-talk between
assemblies of different receptor signaling platforms.
Materials and methods
Reagents
CBC, (
) isoproterenol, atropine, pirenzepine, quercetin, and cytochalasin
D were from Sigma-Aldrich; pertussis toxin was from Research Biochemi-
cals, Inc.; cholera toxin was from List Biological Laboratories, Inc. Brefel-
din A was from Epicentre Technologies; latrunculin B and PP1 were from
Calbiochem. Other chemicals were reagent grade or better.
Antibodies
mAb anti-CL (X-22 and TD.1) and anti-AP2 (AP.6) were from American
Type Culture Collection. Polyclonal anti-CL (COM) and anti-AP-2 (#31)
were gifts from Dr. F. Brodsky (University of California San Francisco, CA)
and Drs. G. Carpenter and A. Sorkin (Vanderbilt University, TN), respec-
tively. Arr3 was detected using affinity-purified rabbit antisera 182–6 (Gai-
darov et al., 1999a). mAb (M2) against the FLAG epitope was from East-
man Kodak Co. mAb antiphosphotyrosine (clone 4G10) was from Upstate
Biotechnology UBI. Fluorescein-, rhodamine-lissamine–, or Cy5-conju-
gated affinity-purified donkey anti–rabbit or anti–mouse polyclonal anti-
bodies were from Jackson ImmunoResearch.
Cell culture
HEK-293 and COS1 cells were obtained from American Type Culture Col-
lection and were grown as specified (Krupnick et al., 1997b). RBL-2H3 cells
stably expressing the human m1 muscarinic receptor (RBL[m1]) (Jones et al.,
1991) were supplied by Dr. M. Beaven (National Institutes of Health, Be-
thesda, MD). RBL-2H3 cells stably expressing a Flag-tagged human 2-adren-
ergic receptor (RBL[2]) were described previously (Santini et al., 2000). Cell
lysis, CL immunoprecipitation, and phosphotyrosine detection were per-
formed as described (Santini and Beaven, 1993; Gaidarov et al., 1999b).
Plasmids and cell transfection
Constructs coding for Flag-2AR (Goodman et al., 1996) and arr3 in which
Leu-373, Ile-374, and Phe-376 were mutated to Ala (arr3-LIF/A) (Krupnick
et al., 1997b) have been described, as has DsRed-CL (Engqvist-Goldstein
et al., 2001). Arr3-R396A was generated by PCR and confirmed by DNA
sequencing. Constructs coding for GFP-arr3 (Mundell et al., 2000), bovine
arr3 short form, and the COOH-terminal region of arr3 (residues 284–409)
(Orsini and Benovic, 1998) were gifts of Dr. J. Benovic (Thomas Jefferson
University, Philadelphia, PA). Transfection was performed as described
(Goodman et al., 1996).
Agonist and pharmacological treatments
Experiments involving RBL cells were performed in a glucose-saline,
PIPES-buffered medium (pH 7.2) that contained 0.1% BSA and 1 mM Ca2
(Santini and Keen, 1996). Experiments involving COS1 cells were per-
formed in Hepes-supplemented complete DME medium (Gaidarov et al.,
1999a). After 10 min equilibration in the experimental buffer, cells were
incubated with the drug or vehicle for the specified period of time before
addition of 1 mM CBC, 10 M ISO, or vehicle. Drugs requiring more than
15 min incubation time (e.g., pertussis and cholera toxins) were added to
cells in complete medium.
The following drugs were added to RBL(m1) cells before stimulation
with CBC (1 mM, 3 min) to probe their effectiveness in inhibiting the ago-
nist effect on CPs: 2 M cytochalasin D for 20 min; 5 g/ml brefeldin A for
40 min; 10 M quercetin for 10 min (Hirasawa et al., 1995); 30 M AlF
4
(prepared by mixing 10 mM NaF with 10 M AlCl3) for 3 min; 1 g/ml
cholera toxin for 4 h (Ali et al., 1990); 0.1 g/ml pertussis toxin for 4 h (Ali
et al., 1990); 10 M AG1478 for 10 min; 10 M PP1 for 15 min. The
m1AChR antagonists atropine (10 M final concentration) and piren-
zepine (0.1 M final concentration) were used as specified in the text. La-
trunculin B was used at 0.6 g/ml. The effect of each of the treatment
alone was also tested in unstimulated cells. Drugs were substituted by ve-
hicle alone in control cells.
Fluorescence microscopy of DsRed-CL 
and GFP-arr3–expressing cells
DsRed-CL and GFP-arr3–expressing cells grown on coverslip-bottom cham-
bers (LabTek) overnight were transferred to warm Hepes 0.1% BSA-supple-
mented serum-free F-12 medium (GIBCO-BRL), placed on the microscope
stage (at 37C), and images were obtained as described previously (Gaidarov
et al., 1999b). CP dynamics (DsRed signal) and mobilization of arr3 (GFP
signal) following addition of ISO were studied on sequences of 100 or 120
images taken using continuous time-lapse recording. An excitation wave-
length alternating between 488 and 554 nm was used which produced a 1.7 s
interval between successive frames of the same channel.
Indirect immunofluorescence and confocal microscopy
Indirect immunofluorescence was performed as described previously (San-
tini and Keen, 1996, 2000). CL was detected using X-22 (30 g/ml), AP-2
with AP.6 (20 g/ml), and arr3 with 182.6 (1:100). F-actin was visualized
using Bodipy 503/512-phallacidin (5 U/ml; Molecular Probes) and primary
antibodies were detected with appropriate tagged second antibodies
(1:100). Images were processed using Adobe Photoshop®.
Evaluation of plasma membrane CPs
CP density and distribution was estimated in cells immunostained for AP-2
and analyzed by confocal x-z scanning as described previously (Santini
and Keen, 1996; Santini et al., 1998). Alternatively, images of cells immu-
nostained for CL or AP-2 were acquired using a widefield system (Santini
and Keen, 2000) as specified above. After determining background level,
50 	 50 pixel boxes were drawn in the cell periphery, and IPLab software
version 3.2.4 (Scanalytics) was used to count CP spots and quantitate their
signal intensity and area.
Electron microscopy
Control RBL(m1) cells and RBL(m1) cells stimulated with CBC for 3 min
were rinsed in 0.1 M cacodylate buffer, pH 7.4, fixed, and processed as
described (Smith et al., 1985). Determination of CP number (Table II) was
performed on 36 and 26 low magnification (13,500	) microphotographs
of control and stimulated cells, respectively. The length of plasma mem-
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brane from cell sections on each photograph was measured and coated
structures and clusters, defined as coated structures 0.3 m apart, were
counted. High magnification photographs (70,200	) were used to classify
coated structures as: (a) “shallow pits” if their depth is less than 1/2 of their
diameter, including flat coated membrane segments; or (b) “deeply invagi-
nated pits” whose depth is 1/2 of their diameter, including putative
“coated vesicles” exhibiting no continuity between the structure and the
plasma membrane. Data are expressed as means  SEM. The Wilcoxon
rank sum/Mann-Whitney test was performed using SYSTAT.
Online supplemental material
Agonist activation induces recruitment of arr3 to preexisting CPs. HEK293
cells coexpressing GFP-arr3, DsRed-CL, and Flag-tagged 2-AR were incu-
bated in 25 mM Hepes-supplemented F-12 medium and viewed on the
37 stage of a microscope. DsRed and GFP signals were alternately ac-
quired with an interval of 1.7 s between frame initiation. Total acquisition
time for the entire sequence was 2.5 min. ISO (10 M) was added 27 s af-
ter the start of the series (between frames 8 and 9). The video is played
back at a speed of 8.33 frames/s. The video is available at http://
www.jcb.org/cgi/content/full/jcb.200110132/DC1.
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Note added in proof. While this work was in press, it was reported that ac-
tivation in live cells of thyrotropin-releasing hormone receptor-1 induced
recruitment of arr3 to spots containing fluorescently tagged eps15, inferred
to be preexisting CPs (Scott, M.G.H., A. Benmerah, O. Muntaner, and S.
Marullo. 2001. J. Biol. Chem. 277:3552–3559).  These results are entirely
consistent with the findings reported here.
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